Stage II Childhood Small Noncleaved Cell Lymphoma Completed Phase 0 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0030350 (Stage II Childhood Small Noncleaved Cell Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs